Apoptotic cell-based therapies against transplant rejection: role of recipient’s dendritic cells
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
One of the ultimate goals in transplantation is to develop novel therapeutic methods for induction of donor-specific tolerance to reduce the side effects caused by the generalized immunosuppression associated to the currently used pharmacologic regimens. Interaction or phagocytosis of cells in early apoptosis exerts potent anti-inflammatory and immunosuppressive effects on antigen (Ag)-presenting cells (APC) like dendritic cells (DC) and macrophages. This observation led to the idea that apoptotic cell-based therapies could be employed to deliver donor-Ag in combination with regulatory signals to recipient's APC as therapeutic approach to restrain the anti-donor response. This review describes the multiple mechanisms by which apoptotic cells down-modulate the immuno-stimulatory and pro-inflammatory functions of DC and macrophages, and the role of the interaction between apoptotic cells and APC in self-tolerance and in apoptotic cell-based therapies to prevent/treat allograft rejection and graft-versus-host disease in murine experimental systems and in humans. It also explores the role that in vivo-generated apoptotic cells could have in the beneficial effects of extracorporeal photopheresis, donor-specific transfusion, and tolerogenic DC-based therapies in transplantation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immunosuppressive effects of apoptotic cells
Voll, R. E., Herrmann, M., Roth, E. A., Stach, C., Kalden, J. R., & Girkontaite, I. (1997) · Nature · doi:10.1038/37022 · Cited by 1,787
Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies
Botto, M., Dell' Agnola, C., Bygrave, A. E., Thompson, E. M., Cook, H. T., Petry, F., Loos, M., Pandolfi, P. P., & Walport, M. J. (1998) · Nature Genetics · doi:10.1038/ng0598-56 · Cited by 1,434 · cited 1×
“Indeed, mice with deficiencies in molecules critical for recognition, internalization, or lysosomal DNA degradation of apoptotic cells, including C1q, C4, IgM, the pentraxin Serum Amyloid P, MerTK, milk fat globule protein-E8, class A scavenger receptors, or lysosomal DNase II develop systemic autoimmune disorders [60…”
BackgroundAlbert, M. L., Pearce, S. F. A., Francisco, L. M., Sauter, B., Roy, P., Silverstein, R. L., & Bhardwaj, N. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.7.1359 · Cited by 1,234
Phagocytosis and clearance of apoptotic cells is mediated by MER
Scott, R. S., McMahon, E. J., Pop, S. M., Reap, E. A., Caricchio, R., Cohen, P. L., Earp, H. S., & Matsushima, G. K. (2001) · Nature · doi:10.1038/35075603 · Cited by 1,215 · cited 1×
“MerTK, a member of the Axl/Mer/Tyro3 receptor tyrosine kinase expressed by DC and macrophages, is a ligand for GAS-6, which binds to externalized PS on apoptotic cells [31–34].”
BackgroundAutoimmune Disease and Impaired Uptake of Apoptotic Cells in MFG-E8-Deficient Mice
Hanayama, R., Tanaka, M., Miyasaka, K., Aozasa, K., Koike, M., Uchiyama, Y., & Nagata, S. (2004) · Science · doi:10.1126/science.1094359 · Cited by 992 · cited 1×
“Indeed, mice with deficiencies in molecules critical for recognition, internalization, or lysosomal DNA degradation of apoptotic cells, including C1q, C4, IgM, the pentraxin Serum Amyloid P, MerTK, milk fat globule protein-E8, class A scavenger receptors, or lysosomal DNase II develop systemic autoimmune disorders [60…”
BackgroundClearance of apoptotic cells by phagocytes
Erwig, L.-P., & Henson, P. M. (2008) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402184 · Cited by 422
Complement deficiencies and systemic lupus erythematosus
Truedsson, L., Bengtsson, A. A., & Sturfelt, G. (2007) · Autoimmunity · doi:10.1080/08916930701510673 · Cited by 315 · cited 1×
“In humans, systemic lupus erythematosus is associated with genetic deficiencies in complement factors [69, 70], and with defective phagocytosis of apoptotic cells [71, 72].”
BackgroundTriggering of Dendritic Cell Responses after Exposure to Activated, but Not Resting, Apoptotic PBMCs
Johansson, U., Walther-Jallow, L., Smed-Sörensen, A., & Spetz, A.-L. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.3.1711 · Cited by 50 · cited 1×
“By contrast, phagocytosis of cells undergoing primary necrosis or dying cells derived from virally-infected, activated or stressed cells promote DC maturation [3, 4, 9–11].”
Background
Cited by
Apoptotic cell clearance: basic biology and therapeutic potential
Poon, I. K. H., Lucas, C. D., Rossi, A. G., & Ravichandran, K. S. (2014) · Nature Reviews Immunology · doi:10.1038/nri3607 · Cited by 1,223
Clearing the Dead: Apoptotic Cell Sensing, Recognition, Engulfment, and Digestion
Hochreiter-Hufford, A., & Ravichandran, K. S. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008748 · Cited by 503
The many ways tissue phagocytes respond to dying cells
Blander, J. M. (2017) · Immunological Reviews · doi:10.1111/imr.12537 · Cited by 84
Metadata
- Authors
- Morelli, A. E., & Larregina, A. T.
- Venue
- Apoptosis
- Published
- 2010-02-06
- Volume
- 15
- Issue
- 9
- Pages
- 1083-1097
- ISSN
- 1360-8185 (ISSN-L)
- 1573-675X
- OpenAlex
- W2045847416
- Cited by
- 70
- References
- 8
- FWCI
- 3.98
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Apoptotic cell-based therapies against transplant rejection: role of recipient’s dendritic cells. https://app.cochat.ai/papers/10.1007/s10495-010-0469-9
- The paper
- Morelli, A. E., & Larregina, A. T. (2010). Apoptotic cell-based therapies against transplant rejection: role of recipient’s dendritic cells. Apoptosis. https://doi.org/10.1007/s10495-010-0469-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.